The director had to deal with John Travolta's bad memory and Gene Hackman's bad attitude during the making of the hit comedy.

Shenzhen-based Pregene Biopharma signed an exclusive licensing agreement with Kite Pharma, a global leader in cell therapy, valued at up to $1.64 billion on Thursday, according to Nanfang Daily's news ...

Prosper Junior Bakiny has positions in Alphabet, Amazon, and Vertex Pharmaceuticals. The Motley Fool has positions in and ...

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors," that control how those genes are read.

Speaking at the STAT Summit, Kyle and Nicole Muldoon shared an inside look at how their family went from heartbreak to ...

In 2024, regulators approved Casgevy, the first CRISPR-based therapy to treat sickle cell disease and beta-thalassemia — a ...

Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the ...

From curing inherited disorders to modifying crops and even animal species, gene editing has moved from science fiction to daily reality—raising questions science can’t ignore.

When startup Pairwise launched Conscious Greens, a line of CRISPR-edited mustard greens, consumers got to experience ...

Maya Ajmera, President & CEO of the Society for Science and Executive Publisher of Science News, spoke with David R. Liu, Thomas Dudley Cabot Professor of ...

One of the most revolutionary tools in cutting-edge medicine is a molecular scalpel so precise that it can modify defective ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Rare Disease Genome Editing Market Through 2025? The market size of genome editing for ...